These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The detection of the factor lowering the immunogenicity of toxoid of Clostridium perfringens type A. Shemanova GF, Vlasova EV, Sergeeva TI, Panteleyev EI. Arch Roum Pathol Exp Microbiol; 1981; 40(4):299-303. PubMed ID: 6280638 [No Abstract] [Full Text] [Related]
3. Comparative study on the immunogenic properties of Clostridium perfringens type A toxoid. Shemanova GF, Vlasova EV, Dmitrieva LN, Trapezov EV, Gorbacheva LD. J Hyg Epidemiol Microbiol Immunol; 1986; 30(3):323-9. PubMed ID: 2877025 [Abstract] [Full Text] [Related]
4. [Factors modulating production of antibodies against Clostridium perfringens in mammals]. Shemanova GF, Sergeeva TI, Panteleev EI, Vlasova EV, Dmitrieva LN. Biull Eksp Biol Med; 1981 Sep; 92(9):322-5. PubMed ID: 6271303 [Abstract] [Full Text] [Related]
7. Antitoxin response in cattle vaccinated with Clostridium perfringens type C toxoid. Kennedy KK, Norris SJ, Beckenhauer WH, White RG. Vet Med Small Anim Clin; 1977 Jul; 72(7):1213-5. PubMed ID: 196381 [No Abstract] [Full Text] [Related]
9. Antitoxin titer in colostrum and milk after vaccination of sows with Clostridium perfringens type C toxoid vaccine. Djurickovic SM, Dworak JE, Wickham KL. Vet Med Small Anim Clin; 1975 Mar; 70(3):283-5. PubMed ID: 164076 [No Abstract] [Full Text] [Related]
12. Vaccination of pregnant sows with Clostridium perfringens type C toxoid. Kennedy KK, Norris SJ, Beckenhauer WH, Hogg A. Vet Med Small Anim Clin; 1977 Jun; 72(6):1047-9. PubMed ID: 194385 [No Abstract] [Full Text] [Related]